Medrio EDC

By the time a new medical product earns regulatory approval and enters post-marketing clinical trials, their eClinical needs change. Phase IV clinical trials are big, involving a large number of patients and data over a longer timeframe, while still employing a relatively simple and straightforward design compared to the more intricate studies of Phase III. Medrio’s popularity in Phase IV derives from the rare ability to cater to both of these aspects simultaneously.

Enter a topic, term or keyword below: